Table 1 Comparisons of serum CCL2, CCL18, and VEGF levels between gastric cancer patients and control groups
From: Predictive value of preoperative serum CCL2, CCL18, and VEGF for the patients with gastric cancer
N | Mean (pg/ml) | Std. deviation | P | |
|---|---|---|---|---|
CCL2 | < 0.001 | |||
Patients | 60 | 25.05 | 1.22 | |
Controls | 20 | 15.95 | 1.15 | |
CCL18 | < 0.001 | |||
Patients | 60 | 115.94 | 22.56 | |
Controls | 20 | 42.46 | 13.97 | |
VEGF | < 0.001 | |||
Patients | 60 | 132.92 | 10.50 | |
Controls | 20 | 59.02 | 6.28 |